• From Research to Venture Capital – Tara Speranza’s journey

  • 2024/07/24
  • 再生時間: 35 分
  • ポッドキャスト

From Research to Venture Capital – Tara Speranza’s journey

  • サマリー

  • Welcome back to the Random VC podcast, where we discuss random topics connected to venture capital, innovation, technology, entrepreneurs, community, and investors. Each episode features five random questions to surprise our guests.In this episode, Maria Halasz chats with Tara Speranza, a trailblazing female VC in Australia, about her diverse journey from academia to venture capital.Tara recounts her early career as a molecular biologist researching endocrine-controlled disorders like osteoporosis. She shares her transition from academia to investment banking, becoming an equity analyst focused on biotech companies. Tara highlights her move to venture capital, discussing the collaborative nature of the field and the importance of detailed financial projections for startups.They explore the growth of the biotech industry, the impact of COVID-19, and the challenges Australian biotech startups face in securing funding. Tara's optimism about the sector's future is evident as she emphasises the importance of understanding expenses for startup success.Maria and Tara also dive into Tara's personal background, including fond childhood memories and her pivot from academia to venture capital. Tara envisions a future blending consulting and venture capital, reflecting her passion for mentoring startups.The episode concludes with Tara answering five random questions, sharing her dinner party guest choices, thoughts on societal kindness, and reflections on her upbringing and values. Tara’s insights offer a comprehensive view of the intersection between science, finance, and investment in the biotech sector.Timestamps:00:19 - Welcome and Tara Speranza's introduction 00:47 - Tara's early career as a molecular biologist01:27 - Researching endocrine-controlled disorders03:16 - Transition to investment banking and becoming an equity analyst06:05 - Move to venture capital and the collaborative nature of the field09:29 - Growth of the biotech industry post-COVID-1913:09 - Challenges for Australian biotech startups in securing funding17:22 - Importance of understanding expenses for startup success20:15 - Tara's childhood memories and family road trips22:11 - Pivot from academia to venture capital25:34 - Vision for the future blending consulting and venture capital29:15 - Five random questions: dinner party guests and societal kindness33:23 - Reflections on upbringing and personal values35:54 - Closing thoughts and future discussionsStay tuned for more insightful conversations on Random VC. Don't forget to subscribe for regular episodes.Want to stay ahead of the curve and never miss an update? Sign up for our newsletter today: https://stride-equity.beehiiv.com/
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Welcome back to the Random VC podcast, where we discuss random topics connected to venture capital, innovation, technology, entrepreneurs, community, and investors. Each episode features five random questions to surprise our guests.In this episode, Maria Halasz chats with Tara Speranza, a trailblazing female VC in Australia, about her diverse journey from academia to venture capital.Tara recounts her early career as a molecular biologist researching endocrine-controlled disorders like osteoporosis. She shares her transition from academia to investment banking, becoming an equity analyst focused on biotech companies. Tara highlights her move to venture capital, discussing the collaborative nature of the field and the importance of detailed financial projections for startups.They explore the growth of the biotech industry, the impact of COVID-19, and the challenges Australian biotech startups face in securing funding. Tara's optimism about the sector's future is evident as she emphasises the importance of understanding expenses for startup success.Maria and Tara also dive into Tara's personal background, including fond childhood memories and her pivot from academia to venture capital. Tara envisions a future blending consulting and venture capital, reflecting her passion for mentoring startups.The episode concludes with Tara answering five random questions, sharing her dinner party guest choices, thoughts on societal kindness, and reflections on her upbringing and values. Tara’s insights offer a comprehensive view of the intersection between science, finance, and investment in the biotech sector.Timestamps:00:19 - Welcome and Tara Speranza's introduction 00:47 - Tara's early career as a molecular biologist01:27 - Researching endocrine-controlled disorders03:16 - Transition to investment banking and becoming an equity analyst06:05 - Move to venture capital and the collaborative nature of the field09:29 - Growth of the biotech industry post-COVID-1913:09 - Challenges for Australian biotech startups in securing funding17:22 - Importance of understanding expenses for startup success20:15 - Tara's childhood memories and family road trips22:11 - Pivot from academia to venture capital25:34 - Vision for the future blending consulting and venture capital29:15 - Five random questions: dinner party guests and societal kindness33:23 - Reflections on upbringing and personal values35:54 - Closing thoughts and future discussionsStay tuned for more insightful conversations on Random VC. Don't forget to subscribe for regular episodes.Want to stay ahead of the curve and never miss an update? Sign up for our newsletter today: https://stride-equity.beehiiv.com/

From Research to Venture Capital – Tara Speranza’s journeyに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。